Growth Metrics

Resmed (RMD) Free Cash Flow (2016 - 2025)

Resmed's Free Cash Flow history spans 17 years, with the latest figure at $311.2 million for Q4 2025.

  • For Q4 2025, Free Cash Flow rose 8.07% year-over-year to $311.2 million; the TTM value through Dec 2025 reached $1.8 billion, up 28.73%, while the annual FY2025 figure was $1.7 billion, 27.65% up from the prior year.
  • Free Cash Flow reached $311.2 million in Q4 2025 per RMD's latest filing, down from $414.4 million in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of $557.9 million in Q1 2025 to a low of -$93.0 million in Q3 2021.
  • Average Free Cash Flow over 5 years is $242.4 million, with a median of $251.6 million recorded in 2023.
  • Peak YoY movement for Free Cash Flow: plummeted 171.26% in 2021, then surged 1541.98% in 2023.
  • A 5-year view of Free Cash Flow shows it stood at $189.5 million in 2021, then crashed by 46.54% to $101.3 million in 2022, then surged by 146.31% to $249.5 million in 2023, then grew by 15.43% to $288.0 million in 2024, then rose by 8.07% to $311.2 million in 2025.
  • Per Business Quant, the three most recent readings for RMD's Free Cash Flow are $311.2 million (Q4 2025), $414.4 million (Q3 2025), and $508.2 million (Q2 2025).